Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 1400701-63-4 | MDL No. : | MFCD28648163 |
Formula : | C5H2Cl2N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QVTSUHXJSAHBAB-UHFFFAOYSA-N |
M.W : | 192.99 | Pubchem ID : | 15740877 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: ethyl 2-methyl-5-tetrazolylacetate With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.0333333h; Stage #2: 2,5-dichloro-4-nitropyridine In N,N-dimethyl-formamide at 20℃; for 0.333333h; Stage #3: With hydrogenchloride In IMS; water for 20h; Heating / reflux; | NaH (60% in mineral oil) (1.2 g) was washed with hexane (1OmL); and mixed with stirring with a solution of (2-methyl-2H-tetrazol-5-yl)acetate (3.25 g, see Chθm. Pharm. Bull., 1991, 1099. - contains other tetrazole isomer also) in anhydrous DMF (20 mL) at 20 0C. The mixture was stirred for 2 minutes at 20 0C under argon, whereupon a solution of 2,5-dichloronitropyridine (3.6 g) dissolved in DMF (10 mL) was added in one portion. The EPO mixture turned dark purple and an exotherm was observed. The mixture was stirred for a further 20 minutes, quenched with 2M HCI (5 ml_) and the DMF was removed in vacuo.The residue was dissolved in ethyl acetate (150 mL), washed with 2M HCI (100 ml_), water (100 mL) and brine (100 mL). The solvent was removed in vacuo to give 5.50 g of crude product, which was dissolved in concentrated HCI (25 mL) and IMS (75 mL) and heated under reflux for 20 hours. The mixture was cooled and extracted into DCM (350 mL); the DCM fraction was washed with water (2 x 300 mL) and brine (100 mL). The solvent was removed in vacuo and the resulting oil purified by column chromatography eluting with 6-35% ethyl acetate in hexane give the products that eluted in the order described.5-chloro-2-[(2-methyl-2H-tetrazol-5-yl)methyl]-3-nitropyridine (0.93g, contaminated with tetrazole starting material) Cf6-DMSO δ 8.90 (1 H, d), 8.74 (1 H,d), 4.31 (3H, s), 4.27 (2H, s).5-chloro-2-[(1-methyl-1 H-tetrazol-5-yl)methyl]-3-nitropyridine as a yellow solid (1.2 g,23%) CZ6-DMSO δ 8.85 (1 H, d), 8.77 (1 H, d), 4.90 (2H, s), 3.97 (3H1 s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 2,5-dichloro-4-nitropyridine; vinyl magnesium bromide In tetrahydrofuran at 0 - 20℃; for 1.66667h; Stage #2: With water; sodium hydrogencarbonate In tetrahydrofuran | 23.2 To a solution of vinylmagnesium bromide (54.04 mmol) in tetrahydrofuran (104 mL) was added a solution of the above crude compound (2.98 g, 15.44 mmol) in tetrahydrofuran (100 mL) at 0°C over 40 minutes, and the mixture was stirred at room temperature for 1 hour. To the reaction solution was added saturated aqueous sodium hydrogen carbonate solution, and the mixture was extracted with ethyl acetate three times. The organic layer was combined, filtered through Phase-separator (Varian Inc.), and then concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate = 80:20→50:50) to give 4,7-dichloro-lH-pyrrolo[3,2-c]pyridine (0.74 g, 27%) as a pale yellow powder.APCI-MS m/z: 187/189[M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 2,5-dichloro-4-nitropyridine-1-oxide With trichlorophosphate In chloroform Reflux; Stage #2: With sodium hydrogencarbonate In chloroform Cooling with ice; | 23.1 To a solution of phosphorus oxychloride (6.40 μ, 73.21 mmol) in chloroform (61.2 mL) was added 2,5-dichloro-4-nitropyridine 1-oxide (3.06 g, 14.64 mmol), and the mixture was stirred under reflux overnight. The reaction solution was poured into ice, adjusted by saturated aqueous sodium hydrogen carbonate solution to pH7 to 8, and extracted with chloroform three times. The organic layer was combined, filtered through Phase-separator (Varian Inc.), and then concentrated under reduced pressure to give a crude 2,5-dichloro-4- nitropyridine (2.98 g, quant.) as a yellow oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: tetrahydrofuran / 1.67 h / 0 - 20 °C 2: potassium carbonate / N,N-dimethyl-formamide / 20 °C |